Policy & Regulation
26 April 2019 - Biopharmaceutical company Symic Bio revealed on Thursday the completion of financings led by Cell Innovation Partners (CIP), a healthcare venture fund started by ReproCELL and Shinsei ...
26 April 2019 - Biotechnology company Stealth BioTherapeutics (NASDAQ:MITO) said on Thursday that it has completed the enrolment of patients with primary mitochondrial myopathy in its MMPOWER-3 (SPIMM...
26 April 2019 - Israel-based Teva Pharmaceutical Industries is halting an ongoing clinical development program of its humanised monoclonal antibody fremanezumab in cluster headaches due to futility, i...
26 April 2019 - Genomic data company Gencove disclosed on Thursday that it has received a Phase I grant from the National Human Genome Research Institute under the auspices of the Small Business Innov...
26 April 2019 - Healthcare company Bausch Health Companies Inc (NYSE/TSX:BHC) and its Ortho Dermatologics dermatology business reported on Thursday the receipt of approval from the US Food and Drug Ad...
26 April 2019 - - US-based clinical-stage biopharmaceutical company X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) has appointed E. Lynne Kelley, M.D., FACS, as the company's chief medical officer, the ...